Failure of heparin to prevent progression in progressing ischemic infarction

Stroke

Volumn 19, Issue 1, 1988, Pages 10-14

  Haley, E C ^a   Kassell, N F ^a   Tomer, J C ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

CEREBRAL INFARCTION; HEPARIN; HUMAN; ISCHEMIC ATTACK, TRANSIENT;

EID: 0023832262     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.19.1.10     Document Type: Article

References (38)

1. ByerJA, Easton JD: Therapy of ischemic cerebrovascular disease. Ann Intern Med 1980;93:742-756
2. Millikan CH, McDowell FH: Treatment of progressing stroke. Stroke 1981;12:397-409
3. Price TR: Progressing ischemic stroke, in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, vol 2. Philadelphia, Churchill Livingstone, 1986, pp 1059-1068
4. Duke RJ, Bloch RF, Turpie AGG, Trebilcock R, Bayer N: Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: A randomized controlled trial. Ann Intern Med 1986;105:825-828
5. Ramirez-Lessepas M, Quinones MR, Nino HH: Treatment of acute ischemic stroke: Open trial with continuous intravenous heparinization. Arch Neurol 1986;43:386-390
6. Teasdale G, Jennett B: Assessment of coma and impaired consciousness: A practical scale. Lancet 1974;2:81-84
7. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL: The Harvard Cooperative Stroke Registry: A prospective registry. Neurology 1978;28: 754-762
8. Fisher CM: Lacunar strokes and infarcts: A review. Neurology 1982;32:871-876
9. Mohr JP: Lacunes. Stroke 1982;13:3-11
10. Putman SF, Adams HP: Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 1985;42:960-962
11. Ramirez-Lassepas M, Quinones MR: Heparin therapy for stroke: Hemorrhagic complications and risk factors for intra-cerebral hemorrhage. Neurology 1984;34:114-117
12. Hedenius P: The use of heparin in internal diseases. Acta Med Scand 1941;107:170-177
13. Baker RH: An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease: A report of the Veterans Administration cooperative study, neurology section. Neurology 1961;11:132-138
14. Fisher CM: Anticoagulant therapy in cerebral thrombosis and cerebral embolism: A national cooperative study, interim report. Neurology 1961;11:119-131
15. Baker RN, Broward JA, Fang HC, Fisher CM, Groch SN, Heyman A, Karp HR, McDevitt E, Scheinberg P, Schwartz W, Toole JF: Anticoagulant therapy in cerebral infarction. Neurology 1962;12:823-835
16. Pearce JMS, Gubbay SS, Walton J: Long-term anticoagulant therapy in transient cerebral ischemic attacks. Lancet 1965;1:6-9
17. Baker RN, Schwartz WS, Rose AS: Transient ischemic attacks: A report of a study of anticoagulant therapy. Neurology 1966;16:841-847
18. Fisher CM: The use of anticoagulants in cerebral thrombosis. Neurology 1958;8:311-332
19. Siekert RG, Whisnant JP, Millikan CH: Surgical and anticoagulant therapy of occlusive cerebrovascular disease. Ann Intern Med 1963;58:637-641
20. Toole JF, Janeway R, Choi K, Cordell R, Davis C, Johnston F, Miller HS: Transient ischemic attacks due to atherosclerosis. Arch Neurol 1975;32:5-12
21. Olsson JE, Muller R, Bemeli S: Long-term anticoagulant therapy for TIAs and minor strokes with minimum residuum. Stroke 1976;7:444-451
22. Carter AB: Anticoagulant treatment in progressing stroke. Br Med J 1961;2:70-73
23. Millikan CH: Anticoagulant therapy in cerebrovascular disease, in Millikan CH, Siekert RG, Whisnant JP(eds): Cerebral Vascular Diseases, Third Princeton Conference. New York, Grune & Stratton, 1961, pp 182-183
24. Marshall J, Shaw DA: Anticoagulant therapy in acute cerebro-vascular accidents: A controlled trial. Lancet 1960;1:995-998
25. Hill AB, Marshall J, Shaw DA: Cerebrovascular disease: Treatment with long-term anticoagulant therapy. Br Med J 1962;2:1003-1006
26. Howard FA, Cohen P, Hickler RB, Locke S, Newcomb T, Tyler HR: Survival following stroke. JAMA 1963;183:921- 925
27. McDowell F, McDevitt E: Treatment of the completed stroke with long-term anticoagulant. Six and one-half years experience, in Siekert RG, Whisnant JP (eds): Cerebral Vascular Diseases, Fourth Princeton Conference. New York, Grune & Stratton, 1965, pp 185-199
28. Enger E, Boyesen S: Long-term anticoagulant therapy in patients with cerebral infarction: A controlled clinical study. Acta Med Scand 1965;178(suppl):1-61
29. Genton E, Barnett HJM, Fields WS, Gent M, Hoak JC: Report of the Joint Committee for Stroke Resources: XIV. Cerebral ischemia: The role of thrombosis and antithrombotic therapy. Stroke 1977;8:148-175
30. Weksler BB, Lewin M: Anticoagulat ion in cerebral ischemia. Stroke 1983;14:658-663
31. Dyken ML: Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke. Neurol Clin 1983;1:223-242
32. Sage JI: Stroke: The use and overuse of heparin in therapeutic trials. Arch Neurol 1985;42:315-317
33. Gautier JC: Stroke-in-progression. Stroke 1985; 16:729-733
34. Bamford J, Sandercock P, Jones L, Warlow C: The natural history of lacunar infarction: The Oxfordshire Community Stroke Project. Stroke 1987;18:545-551
35. Adams HP, Damasio HC, Putman SF, Damagio AR: Middle cerebral artery occlusion as a cause of isolated subcortical infarction. Stroke 1983;14:948-952
36. Pullicino B, Nelson RF, Kendall BE, Marshall J: Small deep infarcts diagnosed by computed tomography. Neurology 1980;30:1090-109
37. Irino T, Watanabe M, Nishide M, Gotoh M, Tsuchiya T: Angiographical analysis of acute cerebral infarction followed by “cascade”-like deterioration of minor neurological deficits. What is progressing stroke? Stroke 1983;14:363-368
38. Turpie AGG, Levine MN, Hirsch J, et al: A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-929